Airway Psychoactive Substance Administration for BCI Integration
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current systems for maintaining mental wellness and integrating brain-computer interfaces (BCIs) face challenges due to signal and circuit incoherence, with users often struggling to achieve restful sleep and engage in relaxing experiences, and existing BCI technologies are limited by their reliance on electrical signals, which can lead to rejection by the brain.
Innovation Solution
The development of systems and methods to automatically administer psychoactive substances through the airway based on detected events or conditions, such as brain wave patterns, sleep cycles, and environmental triggers, using a detection component and an administration component that can release specific substances like GABA, THC, and terpenes to enhance mental wellness and BCI integration.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If electrical signals are used for brain-computer interface communication, then reliable and adaptable neurofeedback circuits can be created, but the brain may reject the direct communication pathway
Solution Approach 1:
The patent introduces psychoactive substances as an intermediary medium between the electrical BCI signals and the brain. These substances are administered through the airway to modulate brain activity and facilitate acceptance of the BCI communication pathway, thereby reducing brain rejection while maintaining circuit reliability
Solution Approach 2:
The system changes the physical and chemical parameters of the communication pathway by introducing psychoactive substances that alter brain state and receptivity. This allows the brain to accept electrical signals more readily by modifying its physiological state through chemical means
2Reliability
If psychoactive substances are administered to enhance BCI integration and mental wellness, then brain signal incoherence is addressed and connections are strengthened, but system complexity increases
Solution Approach 1:
The system combines multiple functions into a single integrated platform that detects brain states, administers psychoactive substances, and monitors BCI communication. This multi-functionality reduces overall system complexity by eliminating the need for separate devices for each function
Solution Approach 2:
The system automatically detects when brain signal incoherence occurs and autonomously administers the appropriate psychoactive substance without requiring manual intervention. This self-service capability simplifies operation while maintaining complex therapeutic functions
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
These systems enable precise administration of psychoactive substances to promote relaxation, improve sleep quality, and strengthen the integration of BCI technologies by addressing brain signal incoherence and enhancing physiological and psychological connections, thereby improving mental wellness and BCI efficacy.
Implementation Method 1
The introducing component is further configured to introduce the psychoactive substance into the respiratory system in, for example, a vaporized form
Implementation Method 2
The introducing component is further configured to introduce the psychoactive substance into the respiratory system in, for example, a vaporized form, in droplets, as small particulates and/or in an aerosolized form
Data Source
AI summary
Described herein are systems and methods for automatically administering a psychoactive substance to a user based on detection of an event or condition during sleep. The systems and methods can be used to promote wellness in personal and research settings, and to facilitate brain-computer interface training, among other beneficial uses.